Aktie A0M39E TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tibet Rhodiola Pharmaceutical Holding Co.

Aktien

A0M39E

CNE000000ZW7

600211

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 13.05.2024 		% 5 Tage % 1. Jan.
38,7 CNY -0,90 % Intraday Chart für Tibet Rhodiola Pharmaceutical Holding Co. +5,45 % +3,09 %
26.04. Tibet Rhodiola Pharmaceutical Holding Co. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
26.03. Tibet Rhodiola Pharmaceutical Holding Co. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Full Year Ended December 31, 2023
Chengdu Nuo´en Genomics Co., Ltd. announced that it has received funding from Jiaxing Anhong Zhifei Venture Capital Partnership (Limited Partnership), Tibet Rhodiola Pharmaceutical Holding Co.
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year Ended June 30, 2023
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Full Year Ended December 31, 2022
Tibet Rhodiola Pharma Unit Becomes Authorized Marketer of Heart Drug
Tibet Rhodiola Pharma Sees 81% Jump in 2022 Profit
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tibet Rhodiola Pharma Wins License to Produce Chest Pain Tablets
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year Ended June 30, 2022
Tibet Rhodiola Pharmaceutical Holding Co.(SHSE:600211) added to Shanghai Stock Exchange A Share Index
Tibet Rhodiola Pharmaceutical Holding Co.(SHSE:600211) dropped from Shanghai Stock Exchange A Share Index
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarter Ended March 31, 2022
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Full Year Ended December 31, 2021
Tibet Rhodiola Pharmaceutical Holding Co.(SHSE:600211) dropped from Shanghai Stock Exchange Health Care Sector Index
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Nine Months Ended September 30, 2021
Tibet Rhodiola Pharmaceutical Holding Co.(XSSC:600211) added to S&P Global BMI Index
Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M39E Aktie
  4. Nachrichten Tibet Rhodiola Pharmaceutical Holding Co.
  5. Andere Sprachen